# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-326065
Filing Date
2018-11-14
Accepted
2018-11-14 06:15:04
Documents
3
Period of Report
2018-11-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d656824d6k.htm | 6-K | 21263
2 | GRAPHIC | g656824g84r04.jpg | GRAPHIC | 639346
3 | GRAPHIC | g656824img1.jpg | GRAPHIC | 8035
| Complete submission text file | 0001193125-18-326065.txt |  | 914338

Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 181180209
SIC: 2834 Pharmaceutical Preparations